Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Non-Current Debt (2018 - 2025)

Historic Non-Current Debt for Dna X (SONM) over the last 6 years, with Q3 2025 value amounting to $250000.0.

  • Dna X's Non-Current Debt changed N/A to $250000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $250000.0, marking a year-over-year change of. This contributed to the annual value of $66000.0 for FY2021, which is 6432.43% down from last year.
  • Latest data reveals that Dna X reported Non-Current Debt of $250000.0 as of Q3 2025.
  • Dna X's 5-year Non-Current Debt high stood at $566000.0 for Q1 2025, and its period low was $30000.0 during Q1 2022.
  • For the 3-year period, Dna X's Non-Current Debt averaged around $160250.0, with its median value being $92500.0 (2021).
  • Data for Dna X's Non-Current Debt shows a peak YoY increase of 5000.0% (in 2022) and a maximum YoY decrease of 7972.97% (in 2022) over the last 5 years.
  • Dna X's Non-Current Debt (Quarter) stood at $66000.0 in 2021, then plummeted by 43.94% to $37000.0 in 2022, then skyrocketed by 575.68% to $250000.0 in 2025.
  • Its last three reported values are $250000.0 in Q3 2025, $566000.0 for Q1 2025, and $37000.0 during Q3 2022.